BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32323837)

  • 1. Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
    Zhou L; Sui H; Wang T; Jia R; Zhang Z; Fu J; Feng Y; Liu N; Ji Q; Wang Y; Zhang B; Li Q; Li Y
    Oncol Rep; 2020 Apr; 43(4):1159-1168. PubMed ID: 32323837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
    Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
    Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.
    Chen MC; Hsu WL; Chang WL; Chou TC
    Sci Rep; 2017 Jul; 7(1):5376. PubMed ID: 28710377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer.
    Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; He Q; Yu W
    Gene; 2020 Sep; 754():144851. PubMed ID: 32525044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
    Yang L; Xiao M; Li X; Tang Y; Wang YL
    Int J Mol Med; 2016 Mar; 37(3):734-42. PubMed ID: 26847718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Lipoxygenase-1 re-expression in colorectal cancer alters endothelial cell features through enhanced expression of TSP-1 and ICAM-1.
    Tunçer S; Keşküş AG; Çolakoğlu M; Çimen I; Yener C; Konu Ö; Banerjee S
    Cell Signal; 2017 Nov; 39():44-54. PubMed ID: 28757355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.
    Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W
    Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling.
    Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H
    Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis.
    Ma H; Pan JS; Jin LX; Wu J; Ren YD; Chen P; Xiao C; Han J
    Cancer Lett; 2016 Jul; 376(2):293-302. PubMed ID: 27080303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1α.
    Kim JY; Song JJ; Kwon BM; Lee JD
    Mol Med Rep; 2015 Sep; 12(3):4604-4609. PubMed ID: 26080622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.
    Wang Y; Li JX; Wang YQ; Miao ZH
    Oncotarget; 2015 Jun; 6(18):16031-42. PubMed ID: 26202747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesamin inhibits hypoxia-stimulated angiogenesis
    Huang Y; Liu Z; Li L; Jiang M; Tang Y; Zhou L; Li J; Chen Y
    Food Funct; 2022 Aug; 13(17):8989-8997. PubMed ID: 35939045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
    Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
    Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer.
    Cui W; Xiao Y; Zhang R; Zhao N; Zhang X; Wang F; Liu Y; Zhang X; Hao J
    Mol Cancer Res; 2021 Sep; 19(9):1498-1509. PubMed ID: 34158392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer.
    Xu Z; Zhu C; Chen C; Zong Y; Feng H; Liu D; Feng W; Zhao J; Lu A
    Cell Death Dis; 2018 Sep; 9(10):974. PubMed ID: 30250188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.